Clinical Trial Update: Admission HbA1C in Aneurysmal Subarachnoid Hemorrhage

View source ↗

Summary

A completed clinical trial assessing admission HbA1C in patients with aneurysmal subarachnoid hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Hyperglycemia, Aneurysmal Subarachnoid Hemorrhage | Status: COMPLETED